Overview
Votrient contains Pazopanib, a tyrosine kinase inhibitor used in targeted cancer therapy. It is prescribed mainly for advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma to inhibit tumor growth by blocking signals that promote cancer cell proliferation and angiogenesis (formation of new blood vessels).





